| Ident. | Authors (with country if any) | Title |
|---|
| 000001 (2020) |
| 新型冠状病毒SARS-CoV-2的变异和进化分析 |
| 000003 (2020) |
Zi-Wei Ye [Hong Kong] ; Shuofeng Yuan [Hong Kong] ; Kit-San Yuen [Hong Kong] ; Sin-Yee Fung [Hong Kong] ; Chi-Ping Chan [Hong Kong] ; Dong-Yan Jin [Hong Kong] | Zoonotic origins of human coronaviruses |
| 000010 (2020) |
| Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19 |
| 000055 (2020) |
Nathan Ford ; Marco Vitoria ; Ajay Rangaraj ; Susan L. Norris ; Alexandra Calmy ; Meg Doherty | Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment |
| 000061 (2020) |
Alexandra C. Walls [États-Unis] ; Young-Jun Park [États-Unis] ; M. Alejandra Tortorici [États-Unis, France] ; Abigail Wall [États-Unis] ; Andrew T. Mcguire [États-Unis] ; David Veesler [États-Unis] | Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein |
| 000066 (2020) |
Kun Li [États-Unis] ; Zhuo Li [États-Unis] ; Christine Wohlford-Lenane [États-Unis] ; David K. Meyerholz [États-Unis] ; Rudragouda Channappanavar [États-Unis] ; Dong An [États-Unis] ; Stanley Perlman [États-Unis] ; Paul B. Mccray [États-Unis] ; Biao He [États-Unis] | Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection |
| 000077 (2020) |
Andrea Cossarizza ; Sara De Biasi ; Giovanni Guaraldi ; Massimo Girardis ; Cristina Mussini | SARS‐CoV‐2, the Virus that Causes COVID‐19: Cytometry and the New Challenge for Global Health |
| 000093 (2020) |
Latif Panahi [Iran] ; Marzieh Amiri [Iran] ; Somaye Pouy [Iran] | Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review |
| 000097 (2020) |
Fang Jiang ; Liehua Deng [République populaire de Chine] ; Liangqing Zhang [République populaire de Chine] ; Yin Cai ; Chi Wai Cheung ; Zhengyuan Xia [République populaire de Chine] | Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) |
| 000099 (2020) |
Lisa E. Gralinski ; Vineet D. Menachery [États-Unis] | Return of the Coronavirus: 2019-nCoV |
| 000132 (2020) |
Boris Krichel ; Sven Falke ; Rolf Hilgenfeld ; Lars Redecke ; Charlotte Uetrecht | Processing of the SARS-CoV pp1a/ab nsp7–10 region |
| 000139 (2020) |
Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong] | Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL
pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates |
| 000144 (2020) |
Helen C. Johnson [Suède] ; Céline M. Gossner [Suède] ; Edoardo Colzani [Suède] ; John Kinsman [Suède] ; Leonidas Alexakis [Suède] ; Julien Beauté [Suède] ; Andrea Würz [Suède] ; Svetla Tsolova [Suède] ; Nick Bundle [Suède] ; Karl Ekdahl [Suède] | Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020 |
| 000146 (2020) |
David A. Schwartz [États-Unis] ; Ashley L. Graham | Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections |
| 000147 (2020) |
Zhong Sun ; Karuppiah Thilakavathy ; S. Suresh Kumar [Malaisie] ; Guozhong He [République populaire de Chine] ; Shi V. Liu [États-Unis] | Potential Factors Influencing Repeated SARS Outbreaks in China |
| 000155 (2020) |
Julien Riou [Suisse] ; Christian L. Althaus [Suisse] | Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 |
| 000166 (2020) |
Robin N. Thompson [Royaume-Uni] | Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations |
**** probable Xml problem ****
| 000194 |
|
